The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

In this article, we are going to take a look at where Kiniksa Pharmaceuticals International ... interesting developments for the UK market. The main stock market index has increased 5.86% since ...

The products will be manufactured at the Verna, Goa facility, and will be marketed & distributed in Australian markets ...

Marksans Pharma shares rose over 4% after its Goa plant secured Australian TGA approval for solid dosage forms. Its UK arm ...

The Association of the British Pharmaceutical Industry is the trade ... Price Action: NVO stock is up 4.23% at $80.41 at the last check on Monday.

Amneal Pharmaceuticals (AMRX) is experiencing significant financial growth by focusing on making generic drugs more affordable and accessible—a ...

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

Read Our Latest Report on BMRN BioMarin Pharmaceutical Trading Down 1.6 % BioMarin Pharmaceutical stock opened at $69.44 on Monday. The company has a quick ratio of 2.62, a current ratio of 5.33 ...

We recently compiled a list of the 10 Best UK Growth Stocks to Buy Now. In this article, we are going to take a look at where Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) stands against ...